Population
In vitro model of the sulfonylurea receptor SUR1 (pancreatic beta-cell KATP channel subunit)
Design
Preclinical
Authors
Loading...
Refines SUR1 nucleotide-binding mechanisms in vitro; leaves open translation to KATP-targeted therapies in patients.
SUR1 strongly binds ATP at NBF1 even in the absence of Mg2+, and MgADP antagonizes this binding through NBF2.
Ueda et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: